Transferrin-mediated increase of labile iron Pool following simulated ischemia causes lipid peroxidation during the early phase of reperfusion

References

• Bou-Abdallah F, Paliakkara JJ, Melman G, et al. Reductive Mobilization of iron from intact ferritin: mechanisms and physiological implication. Pharmaceuticals. 2018;11(4):120.
   Web of Science ®Google Scholar
• Britton RS, Leicester KL, Bacon BR. Iron Toxicity and chelation therapy. Int J Hematol. 2002;76(3):219–228.
   PubMed Web of Science ®Google Scholar
• Paterek A, Mackiewicz U, Mączewski M. Iron and the heart: a paradigm shift from systemic to cardiomyocyte abnormalities. J Cell Physiol. 2019;234(12):21613–21629.
   PubMed Web of Science ®Google Scholar
• Winterbourn CC. Toxicity of iron and hydrogen peroxide: the fenton reaction. Toxicol Lett. 1995;82-83:969–974.
   PubMed Web of Science ®Google Scholar
• Komara JS, Nayini NR, Bialick HA, et al. Brain iron delocalization and lipid peroxidation following cardiac arrest. Ann Emerg Med. 1986;15(4):384–389.
   PubMed Web of Science ®Google Scholar
• Fang X, Wang H, Han D, et al. Ferroptosis as a target for protection against cardiomyopathy. Proc Natl Acad Sci U S A. 2019;116(7):2672–2680.
   PubMed Web of Science ®Google Scholar
• Dixon SJ, Stockwell BR. The Hallmarks of ferroptosis. Annu Rev Cancer Biol. 2019;3(1):35–54.
   Google Scholar
• Halliwell B, Gutteridge JM. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 1990;186:1–85.
   PubMed Web of Science ®Google Scholar
• Dev S, Babitt JL. Overview of iron metabolism in health and disease. Hemodial Int. 2017;21(Suppl 1):s6–s20.
   Google Scholar
• Fontecave M, Pierre JL. Iron metabolism: the low-molecular-mass iron Pool. Biol Metals. 1991;4(3):133–135.
   PubMed Web of Science ®Google Scholar
• Mulligan M, Althaus B, Linder MC. Non-ferritin, non-heme iron pools in rat tissues. Int J Biochem. 1986;18(9):791–798.
   PubMedGoogle Scholar
• Voogd A, Sluiter W, van Eijk HG, et al. Low molecular weight iron and the oxygen paradox in isolated rat hearts. J Clin Invest. 1992;90(5):2050–2055.
   PubMed Web of Science ®Google Scholar
• Zhao G, Ayene IS, Fisher AB. Role of iron in ischemia-reperfusion oxidative injury of rat lungs. Am J Respir Cell Mol Biol. 1997;16(3):293–299.
   PubMed Web of Science ®Google Scholar
• Holt S, Gunderson M, Joyce K, et al. Myocardial tissue iron delocalization and evidence for lipid peroxidation after two hours of ischemia. Ann Emerg Med. 1986;15(10):1155–1159.
   PubMed Web of Science ®Google Scholar
• van der Kraaij AM, Mostert LJ, van Eijk HG, et al. Iron-load increases the susceptibility of rat hearts to oxygen reperfusion damage. Protection by the antioxidant (+)-cyanidanol-3 and deferoxamine. Circulation. 1988;78(2):442–449.
   PubMed Web of Science ®Google Scholar
• Chan W, Taylor AJ, Ellims AH, et al. Effect of iron chelation on myocardial infarct size and oxidative stress in ST-elevation-myocardial infarction. Circ Cardiovasc Interv. 2012;5(2):270–278.
   PubMed Web of Science ®Google Scholar
• Baliga R, Ueda N, Shah SV. Increase in bleomycin-detectable iron in ischaemia/reperfusion injury to rat kidneys. Biochem J. 1993;291 (Pt 3):901–905.
   Google Scholar
• Son E, Lee D, Woo CW, et al. The optimal model of reperfusion injury in vitro using H9c2 transformed cardiac myoblasts. Korean J Physiol Pharmacol. 2020;24(2):173–183.
   PubMed Web of Science ®Google Scholar
• Appleton SD, Chretien ML, McLaughlin BE, et al. Selective inhibition of heme oxygenase, without inhibition of nitric oxide synthase or soluble guanylyl cyclase, by metalloporphyrins at low concentrations. Drug Metab Dispos. 1999;27(10):1214–1219.
   PubMed Web of Science ®Google Scholar
• Chen D, Jin Z, Zhang J, et al. Y. HO-1 protects against hypoxia/Reoxygenation-Induced mitochondrial dysfunction in H9c2 cardiomyocytes. PLoS ONE. 2016;11(5):e0153587.
   PubMed Web of Science ®Google Scholar
• Byrne SL, Buckett PD, Kim J, et al. Ferristatin II promotes degradation of transferrin receptor-1 in vitro and in vivo. PLoS One. 2013;8(7):e70199.
   PubMed Web of Science ®Google Scholar
• Page MA, Baker E, Morgan EH. Transferrin and iron uptake by rat hepatocytes in culture. Am J Physiol. 1984;246(1 Pt 1): g26–33.
   PubMedGoogle Scholar
• Yamaji Y, Nakazato Y, Oshima N, et al. Oxidative stress induced by iron released from transferrin in low pH peritoneal dialysis solution. Nephrol Dial Transplant. 2004;19(10):2592–2597.
   PubMed Web of Science ®Google Scholar
• Grahm G, Bates GW. Approaches to the standardization of serum unsaturated iron-binding capacity. J Lab Clin Med. 1976;88:477–486.
   PubMed Web of Science ®Google Scholar
• Pollack S, Vanderhoff G, Lasky F. Iron removal from transferrin. An experimental study. Biochim Biophys Acta. 1977;497(2):481–487.
   PubMedGoogle Scholar
• Gabbe EE, Heinrich HC, Ičagić F. Proposal for the standardization of the serum unsaturated iron binding capacity assay, and results in groups of subjects with normal iron stores and with prelatent, latent, and manifest iron deficiency. Clin Chim Acta. 1982;119(1-2):51–63.
   PubMed Web of Science ®Google Scholar
• Jenkitkasemwong S, Wang C-Y, Knutson MD. Measurement of transferrin- and non-transferrin-bound iron uptake by mouse tissues. Bio-protocol. 2016;6(17):e1922.
   PubMedGoogle Scholar
• Cabantchik ZI, Glickstein H, Milgram P, et al. A fluorescence assay for assessing chelation of intracellular iron in a membrane model system and in mammalian cells. Anal Biochem. 1996;233(2):221–227.
   PubMed Web of Science ®Google Scholar
• Drummen GP, van Liebergen LC, Op den Kamp JA, et al. C11-BODIPY(581/591), an oxidation-sensitive fluorescent lipid peroxidation probe: (micro)spectroscopic characterization and validation of methodology. Free Radic Biol Med. 2002;33(4):473–490.
   PubMed Web of Science ®Google Scholar
• Rebouche CJ, Wilcox CL, Widness JA. Microanalysis of non-heme iron in animal tissues. J Biochem Biophys Methods. 2004;58(3):239–251.
   PubMedGoogle Scholar
• Rainey NE, Moustapha A, Saric A, et al. Iron chelation by curcumin suppresses both curcumin-induced autophagy and cell death together with iron overload neoplastic transformation. Cell Death Discov. 2019;5(1):150.
   PubMedGoogle Scholar
• Khechaduri A, Bayeva M, Chang HC, et al. Heme levels are increased in human failing hearts. J Am Coll Cardiol. 2013;61(18):1884–1893.
   PubMed Web of Science ®Google Scholar
• Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060–1072.
   PubMed Web of Science ®Google Scholar
• Gao M, Monian P, Quadri N, et al. Glutaminolysis and transferrin regulate ferroptosis. Mol Cell. 2015;59(2):298–308.
   PubMed Web of Science ®Google Scholar
• Feng H, Stockwell BR. Unsolved mysteries: how does lipid peroxidation cause ferroptosis? PLoS Biol. 2018;16(5):e2006203-e2006203.
   Web of Science ®Google Scholar
• Lakhal-Littleton S. Mechanisms of cardiac iron homeostasis and their importance to heart function. Free Radic Biol Med. 2019;133:234–237.
   PubMed Web of Science ®Google Scholar
• Hou W, Xie Y, Song X, et al. Autophagy promotes ferroptosis by degradation of ferritin. Autophagy. 2016;12(8):1425–1428.
   PubMed Web of Science ®Google Scholar
• Luo G, Jian Z, Zhu Y, et al. Sirt1 promotes autophagy and inhibits apoptosis to protect cardiomyocytes from hypoxic stress. Int J Mol Med. 2019;43(5):2033–2043.
   PubMed Web of Science ®Google Scholar
• Dai S, Xu Q, Liu S, et al. Role of autophagy and its signaling pathways in ischemia/reperfusion injury. Am J Transl Res. 2017;9(10):4470–4480.
   PubMed Web of Science ®Google Scholar
• Matsui Y, Takagi H, Qu X, et al. Distinct Roles of autophagy in the heart during ischemia and reperfusion. Circ Res. 2007;100(6):914–922.
   PubMed Web of Science ®Google Scholar
• Gao M, Monian P, Pan Q, et al. Ferroptosis is an autophagic cell death process. Cell Res. 2016;26(9):1021–1032.
   PubMed Web of Science ®Google Scholar
• Lee PJ, Jiang BH, Chin BY, et al. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J Biol Chem. 1997;272(9):5375–5381.
   PubMed Web of Science ®Google Scholar
• Sheftel AD, Kim SF, Ponka P. Non-heme induction of heme oxygenase-1 does not alter cellular iron metabolism. J Biol Chem. 2007;282(14):10480–10486.
   PubMed Web of Science ®Google Scholar
• Tacchini L, Bianchi L, Bernelli-Zazzera A, et al. Transferrin receptor induction by hypoxia. HIF-1-mediated transcriptional activation and cell-specific post-transcriptional regulation. J Biol Chem. 1999;274(34):24142–24146.
   PubMed Web of Science ®Google Scholar
• Chepelev NL, Willmore WG. Regulation of iron pathways in response to hypoxia. Free Radic Biol Med. 2011;50(6):645–666.
   PubMed Web of Science ®Google Scholar
• Page MA, Baker E, Morgan EH. Transferrin and iron uptake by rat hepatocytes in culture. Am J Physiol Gastrointest Liver Physiol. 1984;246:G26–G33.
   PubMed Web of Science ®Google Scholar
• Ali SS, Noordin L, Bakar RA, et al. Current Updates on potential role of flavonoids in hypoxia/reoxygenation cardiac injury model. Cardiovasc Toxicol. 2021;21(8):605–618.
   PubMed Web of Science ®Google Scholar
• Meyron-Holtz EG, Ghosh MC, Rouault TA. Mammalian Tissue oxygen levels modulate Iron-Regulatory protein activities in vivo. Science. 2004;306(5704):2087–2090.
   PubMed Web of Science ®Google Scholar
• Bralet J, Schreiber L, Bouvier C. Effect of acidosis and anoxia on iron delocalization from brain homogenates. Biochem Pharmacol. 1992;43(5):979–983.
   PubMed Web of Science ®Google Scholar
• Braughler JM, Duncan LA, Chase RL. The involvement of iron in lipid peroxidation. Importance of ferric to ferrous ratios in initiation. J Biol Chem. 1986;261(22):10282–10289.
   PubMed Web of Science ®Google Scholar
• Khan S, O'Brien PJ. Modulating hypoxia-induced hepatocyte injury by affecting intracellular redox state. Biochim Biophys Acta. 1995;1269(2):153–161.
   PubMed Web of Science ®Google Scholar
• Yager JY, Brucklacher RM, Vannucci RC. Cerebral oxidative metabolism and redox state during hypoxia-ischemia and early recovery in immature rats. Am J Physiol. 1991;261(4 Pt 2):H1102–1108.
   PubMedGoogle Scholar
• Topham R, Goger M, Pearce K, et al. The mobilization of ferritin iron by liver cytosol. A comparison of xanthine and NADH as reducing substrates. Biochem J. 1989;261(1):137–143.
   PubMed Web of Science ®Google Scholar
• Melman G, Bou-Abdallah F, Vane E, et al. Iron release from ferritin by flavin nucleotides. Biochim Biophys Acta. 2013;1830(10):4669–4674.
   PubMed Web of Science ®Google Scholar
• Presley JF, Mayor S, McGraw TE, et al. Bafilomycin A1 treatment retards transferrin receptor recycling more than bulk membrane recycling. J Biol Chem. 1997;272(21):13929–13936.
   PubMed Web of Science ®Google Scholar
• Ponka P, Lok CN. The transferrin receptor: role in health and disease. Int J Biochem Cell Biol. 1999;31(10):1111–1137.
   PubMed Web of Science ®Google Scholar
• Barañano DE, Rao M, Ferris CD, et al. Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci USA. 2002;99(25):16093–16098.
   PubMed Web of Science ®Google Scholar
• Suttner DM, Sridhar K, Lee CS, et al. Protective effects of transient HO-1 overexpression on susceptibility to oxygen toxicity in lung cells. Am J Physiol. 1999;276(3):L443–451.
   PubMedGoogle Scholar
• Kwon M-Y, Park E, Lee S-J, et al. Heme oxygenase-1 accelerates erastin-induced ferroptotic cell death. Oncotarget. 2015;6(27):24393–24403.
   PubMedGoogle Scholar
• Tacchini L, Fusar Poli D, Bernelli-Zazzera A, et al. Transferrin receptor gene expression and transferrin-bound iron uptake are increased during postischemic rat liver reperfusion. Hepatology. 2002;36(1):103–111.
   PubMed Web of Science ®Google Scholar
• DeGregorio-Rocasolano N, Martí-Sistac O, Ponce J, et al. Iron-loaded transferrin (Tf) is detrimental whereas iron-free Tf confers protection against brain ischemia by modifying blood Tf saturation and subsequent neuronal damage. Redox Biol. 2018;15:143–158.
   PubMed Web of Science ®Google Scholar
• Yang GZ, Xue FS, Liu YY, et al. Feasibility Analysis of Oxygen-Glucose Deprivation-Nutrition resumption on H9c2 cells in vitro models of myocardial Ischemia-Reperfusion injury. Chin Med J (Engl). 2018;131(19):2277–2286.
   PubMed Web of Science ®Google Scholar